VNUS Medical Technologies to Present at FBR Capital Markets 12th Annual Spring Investor Conference

SAN JOSE, Calif., May 22 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices forthe minimally invasive treatment of venous reflux disease, today announced itsplans to present at the FBR Capital Markets 12th Annual Spring InvestorConference, to be held May 28-29, 2008, at the Grand Hyatt New York inNew York, NY.

VNUS' presentation is currently scheduled for 12:50 p.m. ET on Thursday,May 29, and will be webcast on the corporate website athttp://ir.vnus.com/events.cfm. The management speakers will be Brian Farley,President and Chief Executive Officer, and Peter Osborne, Chief FinancialOfficer and Vice President of Finance and Administration.

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasivetreatment of venous reflux disease, a progressive condition that is often theunderlying cause of painful varicose veins. VNUS sells the Closure(R) system,which consists of a proprietary radiofrequency (RF) generator and proprietarydisposable endovenous catheters and devices to close diseased veins throughthe application of temperature-controlled RF energy. Approximately 300,000patients have been treated to date with VNUS Closure catheters. For moreinformation, please visit the corporate website at http://www.vnus.com.

SOURCE VNUS Medical Technologies, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...